NCT02437981View on ClinicalTrials.gov

Evaluation of PrEP-30: a Demonstration Project of Pre-exposure Prophylaxis for MSM and Other High-risk Group Clients at the Thai Red Cross Anonymous Clinic

Enrolling by invitationOBSERVATIONAL
Enrollment

20,000

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2024

Study Completion Date

January 31, 2027

Conditions
HIV Prevention
Interventions
DRUG

PrEP

Oral pre-exposure prophylaxis (PrEP) for HIV infection using a daily combination tablet of tenofovir disoproxil fumarate and emtricitabine

Trial Locations (1)

10330

Thai Red Cross AIDS Research Centre, Bangkok

All Listed Sponsors
lead

Thai Red Cross AIDS Research Centre

OTHER